NCT03786146

Brief Summary

Panretinal photocoagulation reduces the risk of visual loss by 50% in patients with diabetic retinopathy. It is recognized that laser expansion into the retina may be associated with photoreceptor loss, retinal pigment epithelial hypertrophy and visual field loss. Panretinal photocoagulation can cause alteration in retinal vascular permeability therefore, retinal thickness may be increased including retinal nerve fiber layer. On the contrary, it can damage retinal cells including ganglion cells, which may decrease the retinal nerve fiber layer thickness in the latter follow up period. Peripapillary retinal nerve fiber layer can be measured by optical coherence tomography which is a non-invasive technique for obtaining high resolution cross sectional images of a tissue.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jan 2019

Shorter than P25 for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 14, 2018

Completed
10 days until next milestone

First Posted

Study publicly available on registry

December 24, 2018

Completed
8 days until next milestone

Study Start

First participant enrolled

January 1, 2019

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2019

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2019

Completed
Last Updated

December 24, 2018

Status Verified

December 1, 2018

Enrollment Period

10 months

First QC Date

December 14, 2018

Last Update Submit

December 21, 2018

Conditions

Outcome Measures

Primary Outcomes (4)

  • Retinal nerve fiber layer thickness measured by Optical Coherence Tomography (OCT) and expressed in micrometers.

    A 3.4 mm OCT circular scan will be positioned around the optic nerve head.

    0 (before laser treatment ).

  • Retinal nerve fiber layer thickness measured by Optical Coherence Tomography (OCT) and expressed in micrometers.

    A 3.4 mm OCT circular scan will be positioned around the optic nerve head.

    1 month post laser treatment.

  • Retinal nerve fiber layer thickness measured by Optical Coherence Tomography (OCT) and expressed in micrometers.

    A 3.4 mm OCT circular scan will be positioned around the optic nerve head.

    3 months post laser treatment.

  • Retinal nerve fiber layer thickness measured by Optical Coherence Tomography (OCT) and expressed in micrometers.

    A 3.4 mm OCT circular scan will be positioned around the optic nerve head.

    6 months post laser treatment.

Eligibility Criteria

Age40 Years - 70 Years
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

The study will be carried out on patients with a clinical diagnosis of proliferative diabetic retinopathy treated by panretinal photocoagulation.

You may qualify if:

  • Patients with a clinical diagnosis of proliferative diabetic retinopathy.
  • Treated by panretinal photocoagulation.
  • Age between 40-70 years old.

You may not qualify if:

  • Patients with densely opaque media (as dense cataract or vitreous hemorrhage).
  • Glaucomatous patients.
  • Any other associated retinopathy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (6)

  • Wagdy F, El Sobky H, Sarhan AE-R, Hafez M. Evaluation of retinal nerve fiber layer thickness in diabetic retinopathy by optical coherence tomography after full scatter panretinal argon laser photocoagulation. J Egypt Ophthalmol Soc [Internet]. 2013 Jul 1;106(3):153-8. Available from: http://www.jeos.eg.net/article.asp?issn=2090-0686

    BACKGROUND
  • Kim HY, Cho HK. Peripapillary retinal nerve fiber layer thickness change after panretinal photocoagulation in patients with diabetic retinopathy. Korean J Ophthalmol. 2009 Mar;23(1):23-6. doi: 10.3341/kjo.2009.23.1.23. Epub 2009 Mar 9.

    PMID: 19337475BACKGROUND
  • Kim J, Woo SJ, Ahn J, Park KH, Chung H, Park KH. Long-term temporal changes of peripapillary retinal nerve fiber layer thickness before and after panretinal photocoagulation in severe diabetic retinopathy. Retina. 2012 Nov-Dec;32(10):2052-60. doi: 10.1097/IAE.0b013e3182562000.

    PMID: 23099450BACKGROUND
  • Paunescu LA, Schuman JS, Price LL, Stark PC, Beaton S, Ishikawa H, Wollstein G, Fujimoto JG. Reproducibility of nerve fiber thickness, macular thickness, and optic nerve head measurements using StratusOCT. Invest Ophthalmol Vis Sci. 2004 Jun;45(6):1716-24. doi: 10.1167/iovs.03-0514.

    PMID: 15161831BACKGROUND
  • Lim MC, Tanimoto SA, Furlani BA, Lum B, Pinto LM, Eliason D, Prata TS, Brandt JD, Morse LS, Park SS, Melo LA Jr. Effect of diabetic retinopathy and panretinal photocoagulation on retinal nerve fiber layer and optic nerve appearance. Arch Ophthalmol. 2009 Jul;127(7):857-62. doi: 10.1001/archophthalmol.2009.135.

    PMID: 19597104BACKGROUND
  • Muqit MM, Wakely L, Stanga PE, Henson DB, Ghanchi FD. Effects of conventional argon panretinal laser photocoagulation on retinal nerve fibre layer and driving visual fields in diabetic retinopathy. Eye (Lond). 2010 Jul;24(7):1136-42. doi: 10.1038/eye.2009.308. Epub 2009 Dec 18.

    PMID: 20019760BACKGROUND

MeSH Terms

Conditions

Retinal Diseases

Condition Hierarchy (Ancestors)

Eye Diseases

Study Officials

  • rania goda

    researcher in Assiut university

    PRINCIPAL INVESTIGATOR
  • ehab wasfi

    Assiut University

    STUDY DIRECTOR
  • Ali Netag

    Assiut University

    STUDY DIRECTOR
  • Kamel Abd Elnaser

    Assiut University

    STUDY CHAIR

Central Study Contacts

ehab wasfi, assist prof

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CROSSOVER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
principle investigator

Study Record Dates

First Submitted

December 14, 2018

First Posted

December 24, 2018

Study Start

January 1, 2019

Primary Completion

November 1, 2019

Study Completion

December 1, 2019

Last Updated

December 24, 2018

Record last verified: 2018-12